(Press-News.org) Simon Fraser University PhD graduate Maryam Sadeghi will unveil MoleScope™, an innovative hand-held tool that uses a smartphone to monitor skin for signs of cancer, at the World Congress of Dermatology conference in Vancouver June 9-13.
Sadeghi has spent three years transitioning from academic research to her start-up venture, MetaOptima Technology Inc. MoleScope™, the company's inaugural product, which enables people to monitor their moles and skin health, share images with family and healthcare providers and eventually, connect skin specialists with people online.
"I love working with people to help them manage their health," says Sadeghi. "This is exactly what I imagined doing as a student and now my vision is being realized through the launch of MoleScope™, and my company, MetaOptima Technology."
MoleScope™ comprises a mini-microscope that attaches to a smartphone, an app (iOS, Android, or web compatible) and a cloud-based analytical platform called DermEngine™. Once people take high-quality, high-resolution images of suspicious moles or skin abnormalities, they can archive images and communicate concerns with others.
MoleScope™ is expected to provide healthcare benefits in communities without access to medical specialists and in those with long waitlists as people can self-monitor their moles and track changes over time.
Visual changes in skin often signal the possibility of skin cancer. It's estimated that 70 per cent of skin cancer is caught by individuals and family members.
The company has developed two versions of the product: a consumer version expected to retail at $149; and a more expensive professional version being presented at the World Congress of Dermatology meeting.
MoleScope™ has received approval from Health Canada, is FDA registered as a Class 1 medical device in the U.S. and has just received the CE Mark in the EU. TGA approval in Australia is expected shortly. The company is initiating an early adopter program with qualified dermatologists and receiving strong interest from potential distributors and channel partners throughout the world.
Sadeghi is CEO of MetaOptima Technology and the company has grown to nine full-time employees. MetaOptima grew out of the SFU Innovation Office's Venture Connection program and Sadeghi's former mentor in the program, Hugh MacNaught, is now chair of the company's board of directors.
"It was obvious from the outset that Maryam had identified an unmet medical need and that she had strong insights in the application of technology to address that need," says MacNaught. "It has been a pleasure to watch her rally people around her vision and to work tirelessly to make it a reality."
Sadeghi won recognition during the research and development phase of MoleScope™, winning WaveFront's Wireless Prize package ($40,000) in the BCIC-New Ventures Competition in 2013, plus a prize in the Plug & Play Silicon Valley competition in Vancouver in July 2014.
While a graduate student at SFU (she earned a PhD in computing science in 2012 under supervisor and professor emeritus Stella Atkins) Sadeghi and her team also developed the UV Canada app for skin cancer awareness and prevention. It was released in June 2011 and donated to the BC Cancer Agency at Vancouver General Hospital.
Sadeghi's PhD research on skin cancer prevention and analyzing dermoscopic images for early skin cancer diagnosis using intelligent computer technologies was recognized with a 2012 Innovation Challenge Award from the Natural Sciences and Engineering Research Council of Canada.
INFORMATION:
For more information on MetaOptima, visit http://www.molescope.com.
As Canada's engaged university, SFU is defined by its dynamic integration of innovative education, cutting-edge research and far-reaching community engagement. SFU was founded almost 50 years ago, with a mission to be a different kind of university - to bring an interdisciplinary approach to learning, embrace bold initiatives, and engage with communities near and far. Today, SFU is a leader amongst Canada's comprehensive research universities and is ranked one of the top universities in the world under 50 years of age. With campuses in British Columbia's three largest cities - Vancouver, Surrey and Burnaby - SFU has eight faculties, delivers almost 150 programs to over 30,000 students, and boasts more than 130,000 alumni in 130 countries around the world.
Simon Fraser University: Engaging Students. Engaging Research. Engaging Communities
Contact:
Maryam Sadeghi, MetaOptima Technology, 778.892.0248; msa68@sfu.ca
Karen Lee, Faculty of Applied Sciences Communications, 778.782.9523; k_lee@sfu.ca
Marianne Meadahl, University Communications, 778.782.9017; Marianne_Meadahl@sfu.ca
Photos: http://at.sfu.ca/gyqiIk
Two young researchers working at the MIPT Laboratory of Nanooptics and Plasmonics, Dmitry Fedyanin and Yury Stebunov, have developed an ultracompact highly sensitive nanomechanical sensor for analyzing the chemical composition of substances and detecting biological objects, such as viral disease markers, which appear when the immune system responds to incurable or hard-to-cure diseases, including HIV, hepatitis, herpes, and many others. The sensor will enable doctors to identify tumor markers, whose presence in the body signals the emergence and growth of cancerous tumors.
The ...
Two years ago, the Immunology of Diabetes Research Group at the Germans Trias Research Institute (at Universitat Autònoma de Barcelona - Campus of International Excellence Sphere) reported a new experimental immunotherapy that prevented the onset of Type 1 Diabetes in mice predisposed to the disease. This work led to more studies with the support of the Spanish Government, Catalan Government and private patrons with a keen interest in it. Thanks to this, the article published today in PLOS ONE describes a new step towards the creation of a vaccine, which in the medium-term ...
June 9, 2015 - New approaches, based on body mass index (BMI) or other simple measures, are needed to improve assessment of obesity in adolescents with physical disabilities, reports a paper in the American Journal of Physical Medicine & Rehabilitation, the official journal of the Association of Academic Physiatrists. The journal is published by Wolters Kluwer.
Obesity is a major problem in children and adolescents with mobility limitations, but standard assessments tend to underestimate it, according to the new research by Brooks C. Wingo, PhD, of University of Alabama ...
Nagoya, Japan - A team of chemists and biologists at the Institute of Transformative Bio-Molecules (ITbM), Nagoya University have succeeded in finding new molecules that change the circadian rhythm in mammals by applying synthetic chemistry methods, which makes use of highly selective metal catalysts.
Most living organisms have a biological clock with an approximately 24-hour circadian rhythm, which regulates important body functions such as sleep/wake cycles, hormone secretion, and metabolism. Disruption of the circadian rhythm by genetic mutations and environmental ...
LOS ANGELES (JUNE 8, 2015) - The witness on the stand says he saw the accused at the scene of the crime. Is he sure? How sure? The jury's verdict could hinge on that level of certainty.
Many decisions we make every day are influenced by our memories and the confidence we have in them. But very little is known about how we decide whether we can trust a memory or not.
A new Cedars-Sinai study provides some of the answers. Researchers have identified a unique set of neurons in the medial temporal lobe, an area of the brain where memories and memory-based decisions are ...
The use of camera traps -- remote automatic cameras triggered by heat or motion -- has revolutionized wildlife ecology and conservation research. But the large number of images generated through the traps creates the problem of categorizing and analyzing all the images.
For a recent project conducted in the Serengeti National Park, Alexandra Swanson, turned to another relatively new technology -- a citizen science platform. The Snapshot Serengeti project asked non-scientist volunteers to review 1.2 million sets of images. A description of the project, 'Snapshot Serengeti, ...
A variety of factors including questions about risk and reluctance to offend patients limits clinician willingness to prescribe a potentially life-saving medication that counteracts the effects of an opioid overdose, according to a Kaiser Permanente Colorado study published today in the Journal of General Internal Medicine.
The number of fatal overdoses from opioid medications has quadrupled in the U.S. since 1999. According to the Centers for Disease Control and Prevention (CDC), each day 44 people die of prescription painkiller overdoses. In the event of an overdose, ...
American physicians with waivers allowing them to provide office-based medication-assisted buprenorphine treatment to patients addicted to opioids were able to increase potential access to effective medication-assisted treatment by 74 percent from 2002 to 2011, according to a new RAND Corporation study.
Published in the June issue of the journal Health Affairs, the study shows that the increased number and geographic distribution of physicians obtaining waivers to prescribe buprenorphine has widened potential access to effective treatment for those with addiction to heroin ...
Getting through the pollen season can now become easier for some of the approximately 500 million people worldwide who suffer from sneezing and a runny nose, watery eyes and drowsiness during the allergy season (seasonal allergic rhinitis).
This is indicated by a controlled trial carried out by researchers from Aarhus University. The trial, which took place over two days, included 65 people with grass pollen allergies who were not receiving any medical treatment at that time. They were either equipped with a nasal filter or a placebo device.
The conclusion was that the ...
Chicago, June 9, 2015 - A more aggressive approach to treating degenerative mitral valve disease, using earlier surgical intervention and less invasive techniques, is more beneficial to the patient than "watchful waiting," according to an article in the June 2015 issue of The Annals of Thoracic Surgery.
Key points
Earlier surgical intervention using less invasive surgical techniques is better than watchful waiting for patients with degenerative mitral valve disease.
Over the 25 years observed, mortality rates remained low, hospital length of stay was shorter, ...
